topiramate 100 mg

1. Indications and Usage 1.1 Monotherapy Epilepsy Topiramate tablets are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. 1.2 Adjunctive Therapy Epilepsy Topiramate tablets are indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older. 1.3 Migraine Topiramate tablets are indicated for the preventive treatment of migraine in patients 12 years of age and older.

Advanced Rx Pharmacy of Tennessee, LLC

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] fatigue` `[4] off label use` `[5] diarrhoea` `[6] dyspnoea` `[7] pain` `[8] headache` `[9] vomiting` `[10] dizziness`

1 year ago

ROUND YELLOW E 23

1 year ago

E 23 ROUND YELLOW

16. How Supplied/Storage and Handling 16.1 How Supplied

TOPIRAMATE Tablets USP, 100 mg are dark yellow colored, circular, biconvex, beveled edge, film-coated tablets debossed with ‘E’ on one side and ‘23’ on the other side. Bottles of 30 Tablets NDC: 80425-0202-02 16.2 Storage and Handling Store

TOPIRAMATE tablets in tightly-closed containers at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from moisture.

More pills like ROUND E 23

Related Pills

furosemide tablet

ranbaxy pharmaceuticals inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site